SCHEMBL8331917

SCHEMBL8331917

O=Cc1cnc(-c2cc(F)cc(F)c2)s1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.38
▸ HDAC3 O15379 6/20 0.36
▸ HDAC4 P56524 6/20 0.36
▸ HDAC1 Q13547 6/20 0.36
▸ HDAC7 Q8WUI4 6/20 0.36
▸ HDAC2 Q92769 6/20 0.36
▸ HDAC10 Q969S8 6/20 0.36
▸ HDAC11 Q96DB2 6/20 0.36
▸ HDAC8 Q9BY41 6/20 0.36
▸ HDAC6 Q9UBN7 6/20 0.36
▸ HDAC9 Q9UKV0 6/20 0.36
▸ HDAC5 Q9UQL6 6/20 0.36
▸ KCNJ1 P48048 1/20 0.36
▸ HSD17B13 Q7Z5P4 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ MET P08581 1/20 0.34
▸ MAPT P10636 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.32
▸ HRH3 Q9Y5N1 1/20 0.31
▸ CYP2A6 P11509 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1314678 0.83 KDM4E (0.46) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL1314645 0.82 PTPN11 (0.43) ALDH1A1HDAC3HDAC4HDAC1HDAC7
SCHEMBL8336785 0.78 KMO (0.37) ALDH1A1HDAC3HDAC4HDAC1HDAC7
SCHEMBL17099921 0.78 ALDH1A1 (0.48) ALDH1A1HDAC3HDAC4HDAC1HDAC7
SCHEMBL16032766 0.75 HDAC1 (0.48) ALDH1A1HDAC3HDAC4HDAC1HDAC7
SCHEMBL1315529 0.75 HDAC3 (0.39) ALDH1A1HDAC3HDAC4HDAC1HDAC7
SCHEMBL9394 0.74 ALDH1A1 (0.50) ALDH1A1HDAC1HDAC6MAPTKDM4E
SCHEMBL23146389 0.73 CDC7 (0.45) ALDH1A1HDAC3HDAC4HDAC1HDAC7
SCHEMBL31596021 0.72 HDAC9 (0.36) ALDH1A1HDAC3HDAC4HDAC1HDAC7
SCHEMBL14018491 0.72 DCK (0.36) HSD17B13TDP1METKDM4EHRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004058254-A1 HETEROARYLALKANOIC ACIDS AS INTEGRIN RECEPTOR ANTAGONISTS PHARMACIA CORPORATION (US) 2004-07-15 — — WO disclosed
Send feedback